Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma
Clinical trial NCT03278626 · TERMINATED
Trial details
- NCT number
- NCT03278626
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2019-11-07
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.